Can-Fite BioPharma Ltd.
CANF · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.3% | -8.3% | -5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,205.2% | -1,100.9% | -1,244.7% | -1,503.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,169.1% | -1,027.5% | -1,255.9% | -1,476.6% |
| EPS Diluted | -1.08 | -1.8 | -3.75 | -8.25 |
| % Growth | 40% | 52% | 54.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |